167 related articles for article (PubMed ID: 25143805)
1. Silymarin Inhibits Cytokine-Stimulated Pancreatic Beta Cells by Blocking the ERK1/2 Pathway.
Kim EJ; Kim J; Lee MY; Sudhanva MS; Devakumar S; Jeon YJ
Biomol Ther (Seoul); 2014 Jul; 22(4):282-7. PubMed ID: 25143805
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of ERK1/2 by silymarin in mouse mesangial cells.
Youn CK; Cho SI; Lee MY; Jeon YJ; Lee SK
Korean J Physiol Pharmacol; 2017 Jan; 21(1):117-124. PubMed ID: 28066148
[TBL] [Abstract][Full Text] [Related]
3. Radicicol Inhibits iNOS Expression in Cytokine-Stimulated Pancreatic Beta Cells.
Youn CK; Park SJ; Li MH; Lee MY; Lee KY; Cha MJ; Kim OH; You HJ; Chang IY; Yoon SP; Jeon YJ
Korean J Physiol Pharmacol; 2013 Aug; 17(4):315-20. PubMed ID: 23946691
[TBL] [Abstract][Full Text] [Related]
4. Silymarin Inhibits Morphological Changes in LPS-Stimulated Macrophages by Blocking NF-κB Pathway.
Kim EJ; Lee MY; Jeon YJ
Korean J Physiol Pharmacol; 2015 May; 19(3):211-8. PubMed ID: 25954125
[TBL] [Abstract][Full Text] [Related]
5. Silibinin Inhibits LPS-Induced Macrophage Activation by Blocking p38 MAPK in RAW 264.7 Cells.
Youn CK; Park SJ; Lee MY; Cha MJ; Kim OH; You HJ; Chang IY; Yoon SP; Jeon YJ
Biomol Ther (Seoul); 2013 Jul; 21(4):258-63. PubMed ID: 24244809
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of inducible nitric-oxide synthase expression by silymarin in lipopolysaccharide-stimulated macrophages.
Kang JS; Jeon YJ; Kim HM; Han SH; Yang KH
J Pharmacol Exp Ther; 2002 Jul; 302(1):138-44. PubMed ID: 12065710
[TBL] [Abstract][Full Text] [Related]
7. Silymarin protects pancreatic beta-cells against cytokine-mediated toxicity: implication of c-Jun NH2-terminal kinase and janus kinase/signal transducer and activator of transcription pathways.
Matsuda T; Ferreri K; Todorov I; Kuroda Y; Smith CV; Kandeel F; Mullen Y
Endocrinology; 2005 Jan; 146(1):175-85. PubMed ID: 15459112
[TBL] [Abstract][Full Text] [Related]
8. Silibinin modulates TNF-α and IFN-γ mediated signaling to regulate COX2 and iNOS expression in tumorigenic mouse lung epithelial LM2 cells.
Tyagi A; Agarwal C; Dwyer-Nield LD; Singh RP; Malkinson AM; Agarwal R
Mol Carcinog; 2012 Oct; 51(10):832-42. PubMed ID: 21882257
[TBL] [Abstract][Full Text] [Related]
9. Silymarin suppresses TNF-induced activation of NF-kappa B, c-Jun N-terminal kinase, and apoptosis.
Manna SK; Mukhopadhyay A; Van NT; Aggarwal BB
J Immunol; 1999 Dec; 163(12):6800-9. PubMed ID: 10586080
[TBL] [Abstract][Full Text] [Related]
10. Immunosuppressive effect of silymarin on mitogen-activated protein kinase signalling pathway: the impact on T cell proliferation and cytokine production.
Gharagozloo M; Jafari S; Esmaeil N; Javid EN; Bagherpour B; Rezaei A
Basic Clin Pharmacol Toxicol; 2013 Sep; 113(3):209-14. PubMed ID: 23701595
[TBL] [Abstract][Full Text] [Related]
11. A pyrrolidinone derivative inhibits cytokine-induced iNOS expression and NF-kappaB activation by preventing phosphorylation and degradation of IkappaB-alpha.
Katsuyama K; Hirata Y
J Biochem; 2001 Apr; 129(4):585-91. PubMed ID: 11275558
[TBL] [Abstract][Full Text] [Related]
12. Silymarin protects dopaminergic neurons against lipopolysaccharide-induced neurotoxicity by inhibiting microglia activation.
Wang MJ; Lin WW; Chen HL; Chang YH; Ou HC; Kuo JS; Hong JS; Jeng KC
Eur J Neurosci; 2002 Dec; 16(11):2103-12. PubMed ID: 12473078
[TBL] [Abstract][Full Text] [Related]
13. Cytokine-activated p42/p44 MAP kinase is involved in inducible nitric oxide synthase gene expression independent from NF-kappaB activation in vascular smooth muscle cells.
Doi M; Shichiri M; Katsuyama K; Marumo F; Hirata Y
Hypertens Res; 2000 Nov; 23(6):659-67. PubMed ID: 11131279
[TBL] [Abstract][Full Text] [Related]
14. Differential inhibitory actions by glucocorticoid and aspirin on cytokine-induced nitric oxide production in vascular smooth muscle cells.
Katsuyama K; Shichiri M; Kato H; Imai T; Marumo F; Hirata Y
Endocrinology; 1999 May; 140(5):2183-90. PubMed ID: 10218970
[TBL] [Abstract][Full Text] [Related]
15. NO inhibits cytokine-induced iNOS expression and NF-kappaB activation by interfering with phosphorylation and degradation of IkappaB-alpha.
Katsuyama K; Shichiri M; Marumo F; Hirata Y
Arterioscler Thromb Vasc Biol; 1998 Nov; 18(11):1796-802. PubMed ID: 9812920
[TBL] [Abstract][Full Text] [Related]
16. Cytokine-stimulated inducible nitric oxide synthase expression in astroglia: role of Erk mitogen-activated protein kinase and NF-kappaB.
Marcus JS; Karackattu SL; Fleegal MA; Sumners C
Glia; 2003 Jan; 41(2):152-60. PubMed ID: 12509805
[TBL] [Abstract][Full Text] [Related]
17. Silymarin inhibits in vitro T-cell proliferation and cytokine production in hepatitis C virus infection.
Morishima C; Shuhart MC; Wang CC; Paschal DM; Apodaca MC; Liu Y; Sloan DD; Graf TN; Oberlies NH; Lee DY; Jerome KR; Polyak SJ
Gastroenterology; 2010 Feb; 138(2):671-81, 681.e1-2. PubMed ID: 19782083
[TBL] [Abstract][Full Text] [Related]
18. Role of nuclear factor-kappaB activation in cytokine- and sphingomyelinase-stimulated inducible nitric oxide synthase gene expression in vascular smooth muscle cells.
Katsuyama K; Shichiri M; Marumo F; Hirata Y
Endocrinology; 1998 Nov; 139(11):4506-12. PubMed ID: 9794459
[TBL] [Abstract][Full Text] [Related]
19. Evidence for involvement of the proteasome complex (26S) and NFkappaB in IL-1beta-induced nitric oxide and prostaglandin production by rat islets and RINm5F cells.
Kwon G; Corbett JA; Hauser S; Hill JR; Turk J; McDaniel ML
Diabetes; 1998 Apr; 47(4):583-91. PubMed ID: 9568691
[TBL] [Abstract][Full Text] [Related]
20. Preventive effect of silymarin in cerebral ischemia-reperfusion-induced brain injury in rats possibly through impairing NF-κB and STAT-1 activation.
Hou YC; Liou KT; Chern CM; Wang YH; Liao JF; Chang S; Chou YH; Shen YC
Phytomedicine; 2010 Oct; 17(12):963-73. PubMed ID: 20833521
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
